(Q45354931)

13 December 2017

A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge (English)

1 reference

13 December 2017

0 references

1 reference

0 references

Qingwei Liu

1

1 reference

13 December 2017

Kexia Yan

2

1 reference

13 December 2017

Yanfang Feng

3

1 reference

13 December 2017

Xulin Huang

4

1 reference

13 December 2017

Zhiqiang Ku

5

1 reference

13 December 2017

Yicun Cai

6

1 reference

13 December 2017

Fei Liu

7

1 reference

13 December 2017

Jinping Shi

8

1 reference

13 December 2017

Zhong Huang

9

1 reference

13 December 2017

language of work or name

English

0 references

publication date

7 September 2012

1 reference

13 December 2017

1 reference

13 December 2017

30

1 reference

13 December 2017

47

1 reference

13 December 2017

6642-6648

1 reference

Human enterovirus 71 and hand, foot and mouth disease.

13 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.071

Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.071

Genetic diversity of coxsackievirus A16 associated with hand, foot, and mouth disease epidemics in Japan from 1983 to 2003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.071

An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.071

An overview of the evolution of enterovirus 71 and its clinical and public health significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.071

Survey of enterovirus infections from hand, foot and mouth disease outbreak in China, 2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.071

Virology, epidemiology, pathogenesis, and control of enterovirus 71.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.071

EV71: an emerging infectious disease vaccine target in the Far East?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.071

Development of enterovirus 71 vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.071

FATAL COXSACKIEVIRUS A16 INFECTION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.071

Fatal infection in an infant associated with Coxsackie virus group A, type 16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.071

Myocarditis possibly due to Coxsackie group A, type 16, virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.071

Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.071

Virus-like particles as immunogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.071

Virus-like particles: flexible platforms for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.071

Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.071

Quick identification of effective small interfering RNAs that inhibit the replication of coxsackievirus A16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.071

The complete genome of Enterovirus 71 China strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.071

Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.071

Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.071

10.1016/J.VACCINE.2012.08.071

7 January 2021

Identifiers

DOI

1 reference

13 December 2017

1 reference